Total Payments
$9,543
2024 Payments
$522.84
Companies
27
Transactions
101
Medicare Patients
141
Medicare Billing
$47,462
Payment Breakdown by Category
Food & Beverage$5,856 (61.4%)
Travel$3,588 (37.6%)
Education$99.00 (1.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,856 | 76 | 61.4% |
| Travel and Lodging | $3,588 | 24 | 37.6% |
| Education | $99.00 | 1 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $3,406 | 34 | $0 (2022) |
| Penumbra, Inc. | $1,884 | 9 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $726.37 | 6 | $0 (2018) |
| Stryker Corporation | $474.76 | 3 | $0 (2023) |
| Eisai Inc. | $367.86 | 4 | $0 (2018) |
| Ipsen Biopharmaceuticals, Inc | $362.05 | 3 | $0 (2019) |
| Genentech USA, Inc. | $353.69 | 7 | $0 (2019) |
| UCB, Inc. | $330.39 | 5 | $0 (2024) |
| US WorldMeds, LLC | $277.31 | 4 | $0 (2019) |
| phenox Inc. | $196.15 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $522.84 | 10 | Penumbra, Inc. ($256.65) |
| 2023 | $1,936 | 8 | Penumbra, Inc. ($1,558) |
| 2022 | $681.67 | 7 | Medtronic, Inc. ($225.31) |
| 2021 | $3,181 | 31 | Medtronic, Inc. ($3,181) |
| 2019 | $263.71 | 7 | Ipsen Biopharmaceuticals, Inc ($117.18) |
| 2018 | $1,248 | 20 | Genentech USA, Inc. ($262.98) |
| 2017 | $1,709 | 18 | Teva Pharmaceuticals USA, Inc. ($627.37) |
All Payment Transactions
101 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/29/2024 | Penumbra, Inc. | Penumbra System (Device) | Food and Beverage | Cash or cash equivalent | $28.61 | General |
| Category: Neurointervention | ||||||
| 10/28/2024 | Penumbra, Inc. | Penumbra System (Device) | Food and Beverage | Cash or cash equivalent | $146.07 | General |
| Category: Neurointervention | ||||||
| 07/24/2024 | Penumbra, Inc. | Penumbra System (Device) | Food and Beverage | Cash or cash equivalent | $41.12 | General |
| Category: Neurointervention | ||||||
| 07/19/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $25.20 | General |
| Category: NEUROSCIENCE | ||||||
| 07/15/2024 | Penumbra, Inc. | Penumbra System (Device) | Food and Beverage | Cash or cash equivalent | $40.85 | General |
| Category: Neurointervention | ||||||
| 05/29/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: NEUROSCIENCE | ||||||
| 04/25/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $35.89 | General |
| Category: Heart Failure and Hypertension | ||||||
| 04/17/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: NEUROSCIENCE | ||||||
| 03/07/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $36.57 | General |
| Category: Neurology | ||||||
| 02/01/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $129.62 | General |
| Category: NEUROSCIENCE | ||||||
| 12/07/2023 | Penumbra, Inc. | RED 72 (Device) | Food and Beverage | Cash or cash equivalent | $27.94 | General |
| Category: Neurointervention | ||||||
| 09/30/2023 | Penumbra, Inc. | Penumbra System (Device) | Travel and Lodging | Cash or cash equivalent | $820.32 | General |
| Category: Neurointervention | ||||||
| 09/30/2023 | Penumbra, Inc. | Penumbra System (Device) | Food and Beverage | Cash or cash equivalent | $671.41 | General |
| Category: Neurointervention | ||||||
| 09/29/2023 | Stryker Corporation | — | Food and Beverage | In-kind items and services | $165.85 | General |
| 08/14/2023 | Stryker Corporation | — | Food and Beverage | In-kind items and services | $148.65 | General |
| 05/02/2023 | Penumbra, Inc. | Penumbra System (Device) | Food and Beverage | Cash or cash equivalent | $37.88 | General |
| Category: Neurointervention | ||||||
| 05/01/2023 | MicroVention, Inc. | V-GRIP DETACHMENT CONTROLLER (Device), WEB ANEURYSM EMBOLIZATION SYSTEM | Food and Beverage | In-kind items and services | $39.01 | General |
| Category: NEUROLOGICAL PRODUCT | ||||||
| 04/24/2023 | MicroVention, Inc. | WEB ANEURYSM EMBOLIZATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $25.08 | General |
| Category: NEUROLOGICAL PRODUCT | ||||||
| 10/13/2022 | Medtronic, Inc. | PIPELINE (Device) | Food and Beverage | In-kind items and services | $164.82 | General |
| Category: Flow Diversion | ||||||
| 10/13/2022 | Medtronic, Inc. | PIPELINE (Device) | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: Flow Diversion | ||||||
| 10/06/2022 | phenox Inc. | Avenir Coils (Device) | Food and Beverage | In-kind items and services | $196.15 | General |
| Category: Thrombectomy Devices | ||||||
| 09/28/2022 | Stryker Corporation | SURPASS EVOLVE (Device) | Food and Beverage | In-kind items and services | $160.26 | General |
| Category: FLOW DIVERTER | ||||||
| 09/14/2022 | Balt USA, LLC | Optima Coil System (Device) | Food and Beverage | In-kind items and services | $30.55 | General |
| Category: Neurology | ||||||
| 07/13/2022 | Medtronic, Inc. | RIST (Device) | Food and Beverage | In-kind items and services | $35.78 | General |
| Category: Guides and Accessories | ||||||
| 06/08/2022 | Penumbra, Inc. | Penumbra Coil 400 (Device) | Food and Beverage | Cash or cash equivalent | $69.40 | General |
| Category: Neurointervention | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 141 | 181 | $343,590 | $47,462 |
Total Patients
141
Total Services
181
Medicare Billing
$47,462
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 61645 | Removal of blood clot and injection to dissolve blood clot from head artery using fluoroscopic guidance | Facility | 2023 | 20 | 20 | $90,164 | $13,326 | 14.8% |
| 61624 | Occlusion of central nervous system or spinal cord artery | Facility | 2023 | 11 | 12 | $74,726 | $10,737 | 14.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 29 | 59 | $85,004 | $9,956 | 11.7% |
| 36224 | Insertion of tube into internal neck artery for diagnosis or treatment with review by radiologist | Facility | 2023 | 13 | 14 | $27,255 | $4,315 | 15.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 26 | 26 | $26,322 | $3,561 | 13.5% |
| 36223 | Insertion of tube into intracranial artery for diagnosis or treatment with review by radiologist | Facility | 2023 | 12 | 12 | $20,710 | $2,460 | 11.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 14 | 19 | $12,498 | $1,920 | 15.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 16 | 19 | $6,910 | $1,187 | 17.2% |
About Dr. Mohamad Fayad, DO
Dr. Mohamad Fayad, DO is a Vascular Neurology healthcare provider based in Las Vegas, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/23/2015. The National Provider Identifier (NPI) number assigned to this provider is 1053793398.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mohamad Fayad, DO has received a total of $9,543 in payments from pharmaceutical and medical device companies, with $522.84 received in 2024. These payments were reported across 101 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($5,856).
As a Medicare-enrolled provider, Fayad has provided services to 141 Medicare beneficiaries, totaling 181 services with total Medicare billing of $47,462. Data is available for 1 year (2023–2023), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Vascular Neurology
- Location Las Vegas, NV
- Active Since 06/23/2015
- Last Updated 12/01/2022
- Taxonomy Code 2084V0102X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1053793398
Products in Payments
- Pipeline (Device) $1,944
- Penumbra System (Device) $1,786
- KYPHON Balloon Kyphoplasty (Device) $1,237
- COPAXONE (Drug) $521.60
- Fycompa (Drug) $361.76
- Briviact (Drug) $330.39
- Avenir Coils (Device) $196.15
- PIPELINE (Device) $189.53
- SURPASS EVOLVE (Device) $160.26
- NUPLAZID (Drug) $157.08
- QULIPTA (Drug) $154.82
- OCREVUS (Biological) $154.09
- Xadago (Drug) $126.87
- Dysport (Drug) $125.00
- MYOBLOC (Biological) $123.49
- GOCOVRI (Drug) $122.02
- ZINBRYTA (Biological) $120.80
- Dysport 300 U-1 (Drug) $119.87
- DYSPORT (Drug) $117.18
- APTIOM (Drug) $113.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.